Spotlight: Dr. Abir Alatrach on the Cover of Deutsche Dermatologie 06/2024

Dr. Abir Alatrach on the cover of Deutsche Dermatologie, June 2024

We are thrilled to announce that our Dermatology Consultant, Dr Abir Alatrach, has been featured on the cover of Deutsche Dermatologie, a leading academic dermatology magazine by Springer Medizin! Congratulations Dr. Alatrach! We are incredibly proud to have such a distinguished expert on our team. Read the issue here.

Spotlight: CRS at AGAH 2024

The CRS team at the AGAH 2024 Meeting in Münster, Germany

Greetings from the AGAH Annual Meeting 2024 in Münster! Through this year’s theme “Advanced – Divers – Digital”, our team has gained a wealth of insights into cutting-edge translational medicine development, all of which are poised to elevate our daily practices.  A special thank you goes to Sybille Baumann for her pivotal role in organizing this event. As her term as […]

Spotlight: Dr. Atef Halabi at the 130th Conference of the German Society of Internal Medicine (DGIM)

Dr. Halabi attending the DGIM conference in Wiesbaden

Greetings from Wiesbaden! We are thrilled to announce Dr. Halabi’s recent participation in this year’s 130th DGIM Conference, where he actively contributed to discussions on key topics shaping the field of internal medicine. The conference covered a diverse array of subjects, including recent study findings, guidelines, and pertinent clinical matters. His involvement underscores the dedication of […]

CRS appoints Catherine Canales as new Chief Commercial Officer to fuel strategic development and international growth

Catherine Canales, newly appointed Chief Commerical Officer at CRS

Mannheim, Germany, April 10, 2024 – CRS Clinical Research Services, an expert early-phase Contract Research Organization (CRO), announced the appointment of Catherine Canales as Chief Commercial Officer (CCO), effective today, completing the new CRS leadership team. Together, they are committed to steering the company’s strategic development, growth, and innovation on a global scale. Dr. Elisabeth […]

Spotlight: Dr. Yasmina Sahraoui at BIO-Europe Spring 2024

Dr. Yasmina Sahraoui, VP and Deputy Head of Business Development at CRS, attending Bio-Europe Spring 2024

We are delighted to showcase the recent participation of our Vice President and Deputy Head of Business Development, Dr. Yasmina Sahraoui, at Bio-Europe Spring 2024 in Barcelona, Spain. Dr. Sahraoui represented CRS as she connected with life science partners from around the world and engaged with leaders across the global biopharma community to gain insights […]

Spotlight: Dr. Sara Armani at the 9th German Pharm-Tox Summit (DGPT)

Dr. Sara Armani, Head of Medical Affairs

We are thrilled to highlight the recent attendance of our Head of Medical Affairs and Medical Director, Dr. Sara Armani, at the 9th German Pharm-Tox Summit in Munich, Germany. Dr. Armani represented CRS as she engaged in cutting-edge discussions, networked with industry leaders, and gained fresh insights into experimental and clinical pharmacology and toxicology. 

Exciting News: CRS is now a member of Medicon Valley Alliance

Medicon Valley Alliance

We are thrilled to share the news that CRS is now a proud member of Medicon Valley Alliance! Medicon Valley Alliance (MVA) is a non-profit membership organization for the Danish-Swedish life science cluster Medicon Valley. With 300+ members, including universities, hospitals, and businesses, this membership underscores our commitment to staying connected with industry peers, staying […]

Schnappschüsse von dem Netzwerkabend des 13.03.2024: „Therapie der Adipositas“

Mannheim, Deutschland, 18. März 2024 – Am 13. März fand erneut ein „Netzwerkabend“ unseres Forschungsnetzwerkes statt. Bei spannenden Diskussionen zum Thema „Therapie der Adipositas “ unter der Leitung von Prof. Dr. med. Thomas Forst und Dr. med. Friedeborg Seitz hatten die niedergelassenen Kollegen/-innen sowie deren Mitarbeiter die Möglichkeit, unsere Klinik in Mannheim näher kennen zu […]

CRS initiates new chapter by appointing leading industry expert Elisabeth Lackner as Chief Executive Officer

Dr. Elisabeth Lackner, CEO of CRS Clinical Research Services

Mannheim, Germany, March 15, 2024 – CRS Clinical Research Services, an expert early-phase Contract Research Organization (CRO), today announced the appointment of Dr. Elisabeth Lackner as Chief Executive Officer (CEO), effective today. Tasked with leading the organization’s future strategic direction, Dr. Lackner aims to drive internationalization of the business and to enhance the Company’s service […]

Einladung zum Netzwerkabend am 13.03.24

Wir freuen uns, daß die Veranstaltungsreihe “ Netzwerkabend“ unseres Forschungsnetzwerkes wieder regelmäßig stattfindet und laden hiermit herzlich zur nächsten Veranstaltung am 13.03.2024 ein 😊. Der Netzwerkabend dreht sich diesmal um das Thema „Therapie der Adipositas“.   Zusätzlich zu den Vorträgen von Prof. Dr. med. Thomas Forst und Dr. med. Friedeborg Seitz bieten wir den niedergelassenen […]

Opening ceremony new unit Berlin – complete success!

The opening of our new location at the @TechnoCampus Berlin in Spandau was a complete success! The weather played along and we were able to celebrate a new chapter in our company history with our customers and befriended companies in a great atmosphere. And of course we would like to thank our colleagues and all […]

25 Jahre CRS Kiel

Alles begann vor 25 Jahren… Am Freitag, den 28. April 2023, feiert CRS Kiel als ehemaliges „IKP – Institut für Klinische Pharmakologie Prof. Dr. Lücker“ 25-jähriges Firmenjubiläum. Wir freuen uns über diesen Erfolg und auf die nächsten Jahre!

Opening ceremony of our new location in Berlin

Dear friends of CRS Clinical Research Services GmbH, You are very welcome to attend the opening ceremony of our new location in Berlin. When? Thursday, April 20, 2023 12 to 20 pm Where? CRS Clinical Research Services Berlin TechnoCampus Berlin Siemensdamm 65 (Eingang Nikolaus-Groß-Weg) 13627 Berlin Please let us know by April 12, 2023 via […]

Very soon – we are moving to Berlin’s TechnoCampus

The keys for our new Berlin facilities at the TechnoCampus will be handed over next week and the excitement couldn’t be greater!   On March 1, the time has finally come and we will be able to welcome our business partners, healthy volunteers and patients at the new location!   The date for our grand […]

CRS Clinical Research Services Berlin zieht um.

Clinical Trials CRS Mannheim

CRS Clinical Research Services Berlin wird umziehen: von der Sellerstrasse 31 in Wedding in den modernen TechnoCampus am Berliner Siemensdamm. Wir sind glücklich darüber, unsere klinische Forschung dann in neuen, in jeder Hinsicht auf dem neuesten Stand und ganz nach unserem Bedarf ausgestatteten Räumen fortsetzen und robust für die Zukunft ausbauen zu können. In den […]

Herzinsuffizienz und Diabetes

publications

Um auf die Häufigkeit und das zuweilen tödliche Zusammenspiel dieser Erkrankungen vermehrt aufmerksam zu machen, haben die Deutsche Diabetes Gesellschaft (DDG) und die Deutsche Gesellschaft für Kardiologie (DGK) ein erstes gemeinsames Positionspapier herausgegeben. Unser Geschäftsführer und Chief Medical Officer, Prof. Dr. Thomas Forst, war an dessen Ausarbeitung beteiligt Wir freuen uns, Ihnen den Link zur […]

100 Jahre Insulin

2021 jährt sich zum hundertsten Mal ein zentrales Ereignis der Medizingeschichte: Die Isolierung von Insulin. Aus diesem Grund möchten wir Sie recht herzlich zum digitalen Event „100 Jahre Insulin“ einladen. Prof. Dr. Thomas Forst (Geschäftsführer & Chief Medical Officer bei CRS), wird mit seinem Vortrag „Ausblick: Grenzen der subkutanen Insulintherapie – wohin geht der Weg?“ zum […]

Bayer AG and CRS Management GmbH extend strategic partnership

We are proud that the strategic partnership between Bayer AG and CRS Clinical Research Services Management GmbH, which has existed since 2013, has now been extended ahead of schedule, and we are pleased that we may continue to support Bayer AG as a reliable partner in its early clinical development. Bayer AG and CRS look […]

emovis and CRS

CRS clinical research

We are proud to join forces with emovis GmbH in the development of COVID-19 treatments by offering combined clinical trials with healthy volunteers and SARS-CoV-2 patients. For more, see link below. https://www.emovis.de/en/services/covid-trial-unit/